Wall Street winners: Pony AI, ADMA Biologics, Luckin Coffee among top gainers

Bright Spots Amid Market Turbulence: April 28, 2025

Despite persistent economic headwinds and fresh policy uncertainties rattling Wall Street, a group of stocks stood out with impressive gains on April 28, 2025. Autonomous vehicles, biotech breakthroughs, gaming innovation, and retail resilience defined the leaders on a day when markets battled mixed macroeconomic signals. With President Donald Trump’s newly announced tariff escalations and rising inflationary pressures weighing heavily on sentiment, the performances of these companies captured investor attention for different, sector-specific reasons.

Why Did Pony AI Inc. (PONY) Surge 47%?

Pony AI Inc. delivered the day’s strongest performance, skyrocketing by 47.22% to close at $10.32. Trading volumes soared to nearly 69.39 million shares, sharply exceeding the three-month average. Although Pony AI remains down about 41.58% from its 52-week highs, renewed optimism about its progress in autonomous driving technologies, alongside speculation around upcoming partnerships and commercial fleet deployments, fueled the massive surge. Investors appear willing to take speculative positions again in the electric and autonomous driving space, despite wider market caution.

What Boosted Square Enix Holdings Co., Ltd. (SQNNY) by 22%?

Square Enix Holdings Co., Ltd. saw its stock jump 21.77% to finish the day at $25.45, reflecting renewed investor excitement about the Japanese gaming company’s upcoming title releases. Speculation surrounding potential acquisition interest from global technology conglomerates added further momentum. With a 52-week gain of more than 30%, Square Enix is proving resilient in an entertainment sector that has otherwise faced slower growth due to softer discretionary spending trends.

How Did ADMA Biologics, Inc. (ADMA) Gain Over 12%?

ADMA Biologics, Inc. posted a robust 12.12% rise to $24.51 as investors reacted positively to developments in its plasma-based therapies pipeline. Biotech continues to outperform much of the broader market, and ADMA’s triple-digit 232.22% 52-week performance reflects sustained demand for specialized immunological treatments. Institutional flows into small and mid-cap biotech companies have been on the rise in recent weeks, providing additional technical support to ADMA’s rally.

Is TechnoPro Holdings, Inc. (TXHPF) a Quiet Growth Story?

TechnoPro Holdings, Inc. advanced by 11.31% to $20.03, riding on the back of demand for engineering and consulting expertise amid a global infrastructure boom. The Tokyo-based firm benefited from contract wins across renewable energy, telecoms, and construction sectors. Although its 52-week gain remains modest at 7.43%, analysts view the company’s diversified revenue streams as a strong buffer against macroeconomic turbulence.

Why Biohaven Ltd. (BHVN) Gained 10% Despite Challenges

Biohaven Ltd. rose by 9.58% to $21.74, with investors betting on its late-stage neurology drug candidates. The stock remains down by more than 50% compared to a year ago, reflecting volatility in the biotech space. However, sentiment turned positive after recent regulatory filings indicated steady progress across key clinical programs, making Biohaven a speculative rebound play for risk-tolerant investors.

Which Other Stocks Gained Sharply on April 29, 2025?

OVH Groupe S.A. climbed 8.70% to $13.75 as the European cloud services provider capitalized on enterprise digital transformation trends. Oatly Group AB advanced by 7.53% to $10.00 after announcing expanded distribution partnerships across North America, boosting hopes for a turnaround in the plant-based food segment. Entain Plc gained 7.04% to close at $8.36, supported by robust growth in its Latin American sports betting operations despite regulatory overhangs in core European markets.

VEON Ltd. moved up by 6.97% to $45.60, reflecting optimism in emerging market telecoms after stronger-than-expected mobile subscriber growth. Revolution Medicines, Inc. rose 6.96% to $41.47 following encouraging updates on its precision oncology drug candidates. Luckin Coffee Inc. climbed 6.40% to $35.10, extending its remarkable recovery story in the competitive Chinese coffee market.

Highest Performances Holdings Inc. posted a 6.37% gain to $8.18, although it remains down more than 98% over the last year, making it highly speculative. Wayfair Inc. gained 6.05% to $31.02 as discount-driven consumer demand slightly revived the struggling e-commerce sector. Anglo American Platinum Limited advanced 5.71% to $5.92 amid a modest rebound in precious metals prices.

Hitachi, Ltd. added 5.57% to reach $27.84, supported by strong global demand for railway systems and industrial automation products. Bath & Body Works, Inc. rose 5.54% to $31.22 after reporting stabilizing same-store sales trends. Aurora Innovation, Inc. increased 5.52% to $7.26, joining other autonomous vehicle firms in posting outsized gains.

Verona Pharma plc gained 5.15% to $68.83 after promising COPD drug data impressed analysts. AppFolio, Inc. added 4.93% to $201.49 on the back of strong subscription growth within its property management software segment. Peloton Interactive, Inc. rose 4.93% to $6.60 after recent layoffs and restructuring were positively received by markets.

ZEEKR Intelligent Technology Holding Limited gained 4.86% to $22.02 as investors repositioned into next-generation electric vehicle players. Immunovant, Inc. climbed 4.76% to $15.42 driven by optimism surrounding its autoimmune disease programs. Intercorp Financial Services Inc. rose 4.64% to $33.62 after posting better-than-expected loan growth figures from Peru.

CEMEX, S.A.B. de C.V. added 4.56% to $6.19 as infrastructure stimulus measures in Latin America bolstered construction material demand. Rivian Automotive, Inc. ended the day higher by 4.52% at $13.19 amid growing optimism about U.S. government incentives for electric vehicle buyers.

What Broader Economic Trends Are Shaping the Market?

The broader U.S. economy remains caught between persistent inflation and fears of policy missteps. President Donald Trump’s new tariffs targeting multiple industries have reignited fears of global trade wars, pressuring multinational companies. The Federal Reserve continues its delicate balancing act, holding interest rates steady while closely monitoring wage pressures and labor market data. Analysts expect that upcoming CPI readings and Nonfarm Payrolls reports will significantly impact the market’s trajectory through May.

Sector-specific challenges also remain in focus. The technology sector, while showing strength through names like Pony AI and Aurora Innovation, faces rising regulatory scrutiny over artificial intelligence governance. Biotech companies, despite recent gains, remain vulnerable to upcoming healthcare reforms that could pressure drug pricing models. Consumer discretionary firms such as Bath & Body Works and Wayfair continue to face margin compression even as sales stabilize.

Energy markets also remain volatile, with platinum and other industrial commodities showing modest recoveries but remaining sensitive to geopolitical risks in the Middle East and broader OPEC+ production decisions.

Investor Sentiment: Cautious Optimism or Temporary Rebound?

Despite impressive gains among select stocks, broader investor sentiment remains cautious. Institutional investors continue favoring quality and defensive names, while retail investors increasingly target high-beta, speculative plays during short-term rallies. Analysts advise maintaining disciplined risk management, highlighting that the path forward will depend heavily on macroeconomic data surprises, Federal Reserve communications, and global political developments in the coming weeks.